Maltodextrin, dextrose equivalent 16.5-19.5
CAT:
804-HY-W250795-02
Size:
500 g
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Maltodextrin, dextrose equivalent 16.5-19.5
- CAS Number: 9050-36-6
- UNSPSC Description: Maltodextrin, dextrose equivalent 16.5-19.5 can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1].
- Target Antigen: Endogenous Metabolite
- Type: Reference compound
- Related Pathways: Metabolic Enzyme/Protease
- Applications: Metabolism-protein/nucleotide metabolism
- Field of Research: Others; Cancer
- Assay Protocol: https://www.medchemexpress.com/maltodextrin-dextrose-equivalent-16-5-19-5.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H](COC)O[C@H](O[H])[C@H](O)[C@H]2O)O1.[y].[x]
- References & Citations: [1]Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99.
- Shipping Conditions: Room Temperature
- Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
- Clinical Information: Phase 4